Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
Select for export Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.1c06708 PubMed 35187358 Copy citation Copy BibTeX ACS Omega 2022-02-06 Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. Europe PMC Published psilocybinpsilocin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11019-022-10070-7 PubMed 35064398 Copy citation Copy BibTeX Unknown journal 2022-01-21 Miceli McMillan R, Jordens C. Europe PMC Published psilocybin Depression Other More
Select for export Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1714-9097 PubMed 35045580 Copy citation Copy BibTeX Unknown journal 2022-01-18 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Systematic Review More
Select for export Neurochemical properties of psilocybin in comparison to ketamine in vivo No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100408 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Psilocybin may be effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.164911 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_282 PubMed 34811715 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Agin-Liebes G, Davis AK. Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1076459 PubMed 36844032 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM PubMed Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
Select for export Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jns.2021.120096 PubMed 34942586 Copy citation Copy BibTeX Unknown journal 2021-12-15 Pearson C, Siegel J, Gold JA. Europe PMC Published psilocybin DepressionPharmacologyClinical Trial Clinical Trial More
Select for export A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.727572 PubMed 34950063 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-12-06 Whitfield HJ. Europe PMC Published psilocybin DepressionPTSDMechanism of Action Review Article More
Select for export P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.394 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle OpenAlex Published psilocybin DepressionConsciousnessSafety Other More
Select for export Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2021-056091 PubMed 34853114 Copy citation Copy BibTeX BMJ Open 2021-11-30 Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G Europe PMC Published psilocybin DepressionBrain ImagingBiomarkers Randomized Controlled Trial More
Select for export Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40263-021-00877-y PubMed 34791625 Copy citation Copy BibTeX Unknown journal 2021-11-16 Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Review Article More
Select for export From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.15509 PubMed 34519052 Copy citation Copy BibTeX Unknown journal 2021-10-21 Kozlowska U, Nichols C, Wiatr K, Figiel M. Europe PMC Published psilocybin DepressionAddictionNeuroplasticity Clinical Trial More
Select for export Novel antidepressant drugs: Beyond monoamine targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852921000791 PubMed 34588093 Copy citation Copy BibTeX Unknown journal 2021-09-29 Gonda X, Dome P, Neill JC, Tarazi FI. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1027/1016-9040/a000447 Copy citation Copy BibTeX European Psychologist 2021-09-16 Matthias Forstmann, Christina Sagioglou OpenAlex Published psilocybin DepressionAnxietyAddiction Review Article More
